Jun Hee Hong

551 total citations
15 papers, 202 citations indexed

About

Jun Hee Hong is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jun Hee Hong has authored 15 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jun Hee Hong's work include Synthesis and biological activity (5 papers), Melanoma and MAPK Pathways (3 papers) and Click Chemistry and Applications (2 papers). Jun Hee Hong is often cited by papers focused on Synthesis and biological activity (5 papers), Melanoma and MAPK Pathways (3 papers) and Click Chemistry and Applications (2 papers). Jun Hee Hong collaborates with scholars based in Australia, South Korea and Egypt. Jun Hee Hong's co-authors include Kyung Ho Yoo, Mohammed I. El‐Gamal, So Ha Lee, Chang‐Hyun Oh, Hong Seok Choi, Tae Bo Sim, Chang-Hyun Oh, Eun Young Choi, Ju Young Park and Hyunggee Kim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jun Hee Hong

13 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Hee Hong Australia	8	104	88	40	31	21	15	202
Jeanelle McSurdy-Freed United States	9	128 1.2×	45 0.5×	56 1.4×	18 0.6×	15 0.7×	9	246
Debra G. Goodwin United States	5	92 0.9×	45 0.5×	27 0.7×	18 0.6×	14 0.7×	7	257
Kunwar Somesh Vikramdeo United States	12	150 1.4×	37 0.4×	42 1.1×	66 2.1×	30 1.4×	24	272
Jitendra K. Mishra India	7	113 1.1×	103 1.2×	35 0.9×	22 0.7×	10 0.5×	20	238
Kohei Ohata Japan	9	55 0.5×	83 0.9×	55 1.4×	13 0.4×	32 1.5×	14	207
Laurent Désaubry France	6	240 2.3×	51 0.6×	33 0.8×	25 0.8×	11 0.5×	10	305
Yuandi Gao Canada	8	181 1.7×	31 0.4×	57 1.4×	34 1.1×	25 1.2×	12	280
Ryan Stansfield United States	8	281 2.7×	60 0.7×	53 1.3×	26 0.8×	6 0.3×	11	355
Alastair Donald United Kingdom	6	202 1.9×	117 1.3×	45 1.1×	9 0.3×	8 0.4×	8	274
Jen-Shin Song Taiwan	10	111 1.1×	86 1.0×	24 0.6×	7 0.2×	22 1.0×	14	254

Countries citing papers authored by Jun Hee Hong

Since Specialization

Citations

This map shows the geographic impact of Jun Hee Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Hee Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Hee Hong more than expected).

Fields of papers citing papers by Jun Hee Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Hee Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Hee Hong. The network helps show where Jun Hee Hong may publish in the future.

Co-authorship network of co-authors of Jun Hee Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Hee Hong. A scholar is included among the top collaborators of Jun Hee Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Hee Hong. Jun Hee Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hong, Martin, Jun Hee Hong, George Au‐Yeung, et al.. (2025). Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters—AI-OncLetters. JCO Clinical Cancer Informatics. 9(9). e2400323–e2400323.

Hong, Jun Hee, Joseph Descallar, Martin Hong, et al.. (2025). Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study. JCO Oncology Practice. OP2500412–OP2500412.

Hong, Jun Hee, et al.. (2022). A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour. SHILAP Revista de lepidopterología. 15(3). 1055–1062. 2 indexed citations

Hong, Jun Hee, et al.. (2022). Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer. Clinical Genitourinary Cancer. 21(1). 183–193. 9 indexed citations

Harris, Carole A., Matthew Tong, Jun Hee Hong, et al.. (2022). Immune Checkpoint Inhibitor-Induced Myocarditis, Myositis, Myasthenia Gravis and Transaminitis: A Case Series and Review. Immunotherapy. 14(7). 511–520. 8 indexed citations

Kwon, Hyung Joon, Young Taek Oh, Sung Soo Kim, et al.. (2021). Analysis of electric cigarette liquid effect on mouse brain tumor growth through EGFR and ERK activation. PLoS ONE. 16(9). e0256730–e0256730. 7 indexed citations

Hong, Jun Hee, et al.. (2019). Benchmarking single-arm studies against historical controls from non-small cell lung cancer trials – an empirical analysis of bias. Acta Oncologica. 59(1). 90–95. 6 indexed citations

Roberts, Kate, Robert M. Mason, Jun Hee Hong, et al.. (2018). Immune-related adverse events and nivolumab outcomes in non-small cell lung cancer patients: A multi-institutional, retrospective cohort study.. Journal of Clinical Oncology. 36(15_suppl). 9067–9067. 7 indexed citations

Yin, Jinlong, Jeong Eun Lee, Eun Young Choi, et al.. (2015). DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis. Brain. 138(9). 2553–2570. 65 indexed citations

10.

El‐Gamal, Mohammed I., Chang-Hyun Oh, So Ha Lee, et al.. (2013). New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: Synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies. European Journal of Medicinal Chemistry. 70. 10–21. 27 indexed citations

11.

El‐Gamal, Mohammed I., Chang‐Hyun Oh, So Ha Lee, et al.. (2012). Synthesis and Antiproliferative Activity of New Aminoisoquinolinylurea Derivatives against Melanoma Cell Line. Bulletin of the Korean Chemical Society. 33(11). 3635–3639. 16 indexed citations

12.

El‐Gamal, Mohammed I., et al.. (2011). Design, Synthesis, and Antiproliferative Activity of 3,4‐Diarylpyrazole‐1‐carboxamide Derivatives Against Melanoma Cell Line. Archiv der Pharmazie. 344(11). 745–754. 10 indexed citations

13.

El‐Gamal, Mohammed I., Tae Bo Sim, Jun Hee Hong, et al.. (2010). Synthesis of 1H‐Pyrazole‐1‐carboxamide Derivatives and Their Antiproliferative Activity against Melanoma Cell Line. Archiv der Pharmazie. 344(3). 197–204. 13 indexed citations

14.

Kim, Han Jo, Il Hwan Kim, Mohammed I. El‐Gamal, et al.. (2009). Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma. Bioorganic & Medicinal Chemistry Letters. 20(1). 413–417. 28 indexed citations

15.

Jeong, Lak Shin, Hyung Ryong Moon, Jun Hee Hong, et al.. (2001). STRUCTURE-ACTIVITY RELATIONSHIPS OF APIO NUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 657–660. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact